Cargando…
Potential drug‐drug interaction between tolvaptan and warfarin in a geriatric patient with heart failure
Tolvaptan is a key drug for patients with heart failure. Here, we present a 92‐year‐old woman, whose PT‐INR/dose increased from 1.74 to 3.30 after warfarin and tolvaptan co‐administration, and resulted in a large cerebral infarction after warfarin dose down. Therefore, the interaction between these...
Autores principales: | Nimura, Satomi, Kitahara, Kanayuki, Ueshima, Kazuyo, Mochizuki, Yasuhide, Momo, Kenji, Shinke, Toshiro, Sasaki, Tadanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978989/ https://www.ncbi.nlm.nih.gov/pubmed/35414910 http://dx.doi.org/10.1002/ccr3.5592 |
Ejemplares similares
-
Cerebral embolism as initial manifestation of left ventricular endomyocardial fibrosis mimicking intracardiac tumour
por: Arai, Taito, et al.
Publicado: (2022) -
Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011) -
Tolvaptan- and
Tolvaptan-Metabolite-Responsive T Cells
in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020) -
Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018) -
A case report of platypnea-orthodeoxia syndrome: A rare condition found during diagnostic workup of a patient with embolic stroke of undetermined sources
por: Mizuma, Keita, et al.
Publicado: (2022)